Most importantly, treatment of colorectal cancer cells with these agents, butnot treatment of normal colonic epithelial cells or embryonic stem cells, triggered cell growtharrest and, again, blocked the expression of target genes that are activated by MYC, withoutaffecting those that are repressed by MYC. Here, MYC is linked to colorectal cancer.